Edgewell Personal Care Company Revenue & Financials

Edgewell Personal Care reported FY2024 net sales of $2,253.7 million, an increase of $2.1 million or 0.1% from $2,251.6 million in FY2023. Organic net sales increased 0.2%, as 7.3% growth in international markets—reflecting both increased volumes and price—was partially offset by a 3.8% decrease in North America organic net sales, primarily reflecting volume declines in Feminine Care, Wet Shave, and Wet Ones, partially offset by organic growth across Sun Care and Grooming. The Wet Shave segment generated $1,229.3 million in FY2024 sales, down 0.1% from $1,230.9 million in FY2023, with organic net sales up 0.2%. Segment profit was $203.9 million, up 28.8% from $158.3 million in FY2023, with organic segment profit up 29.9%. This profit expansion reflected higher gross margin and lower marketing expense, demonstrating the segment's operating leverage when volume is stable. The Sun and Skin Care segment generated $740.8 million in FY2024 sales, up 5.0% from $705.5 million in FY2023, with organic net sales up 4.6%. Growth was driven by Sun Care growth of 9.1% in international markets and 6.1% in North America, as well as 5.5% growth in global Grooming. These increases were partially offset by lower sales in Wet Ones primarily due to unfavorable volume impact related to the fire at the Sidney, Ohio manufacturing plant. Segment profit was $131.3 million, down 4.4% from $137.4 million in FY2023, with organic segment profit down 5.3%. The decline was driven by higher SG&A and marketing expenses, partially offset by higher gross margins. The Feminine Care segment generated $283.6 million in FY2024 sales, down 10.0% from $315.2 million in FY2023, with organic net sales down 10.0%. The decline was primarily related to volume decline in tampons and pads. Segment profit was $28.8 million, down 42.1% from $49.7 million in FY2023, reflecting lower organic net sales and the resulting unfavorable impact on gross profit. Gross profit was $955.7 million, up 1.6% from $940.8 million in FY2023, with gross margin of 42.4% compared to 41.8% in the prior year. Adjusted gross margin increased 140 basis points, as productivity savings of approximately 280 basis points and favorable price of approximately 115 basis points more than offset core inflation and transitory cost headwinds of approximately 185 basis points and unfavorable mix of approximately 70 basis points. Selling, general, and administrative expenses were $430.1 million, or 19.1% of net sales, up from $409.6 million or 18.2% in FY2023. Adjusted SG&A increased 40 basis points to 18.5% of net sales, driven by higher people expenses, legal costs, and broker costs, partially offset by operational efficiency savings, lower bad debt expense, and lower incentive compensation expense. Advertising and sales promotion expenses were $232.0 million, or 10.3% of net sales, essentially flat with FY2023. Research and development expenses were $58.4 million, or 2.6% of net sales. The company recorded $35.9 million in restructuring charges in FY2024, up from $16.6 million in FY2023. This included a $15.6 million charge related to consolidating Mexico operations and other organizational streamlining. Additional special items in FY2024 included $12.2 million in costs from the Wet Ones manufacturing plant fire, $4.4 million in sun care reformulation costs, $3.9 million in legal matter settlements, $3.1 million in loss on investment, and $5.3 million in other project costs. Operating income was $199.3 million, down 12.2% from $227.0 million in FY2023, with operating margin of 8.8% compared to 10.1%. Interest expense associated with debt was $76.5 million, down from $78.5 million in FY2023. Other expense was $1.9 million compared to $0.8 million in FY2023. Earnings before income taxes were $120.9 million, down 18.1% from $147.7 million in FY2023. The income tax provision was $22.3 million, down from $33.0 million in FY2023, with an effective tax rate of 18.4% compared to 22.3% in FY2023. Net earnings were $98.6 million, down 14.0% from $114.7 million in FY2023. Diluted EPS was $1.97 compared to $2.21 in FY2023. Adjusted diluted EPS was $3.21 in FY2024, up from $2.83 in FY2023, representing 13.4% growth. Cash provided by operating activities was $216.1 million, up from $102.0 million in FY2023. Capital expenditures were $49.5 million. Free cash flow was approximately $166.6 million. The balance sheet as of September 30, 2024, showed total assets of $3,913.2 million, total liabilities of $2,978.1 million, and shareholders' equity of $935.1 million. Total debt was approximately $1.9 billion, with a debt-to-equity ratio of approximately 2.0x. The company's market capitalization as of June 2026 was approximately $935 million, with a stock price of $20.28 per share. The stock trades at a price-to-sales ratio of 0.41, a price-to-book ratio of 0.63, and an enterprise value-to-revenue ratio of 0.85—valuations that reflect investor skepticism about growth prospects. The dividend yield of 2.96% and payout ratio of approximately 30% provide income support. Revenue per employee was approximately $336,000 in FY2024.